Phase 4
Completed N=20
Absorption Comparison on Equivalency Value of Genepro Gen2
Analysis, Event History · Absorption; Disorder, Protein
Source: ClinicalTrials.gov NCT02919657 ↗
Enrolled (actual)
20
Serious AEs
—
Results posted
Dec 2016
Primary outcomePrimary: Weekly Blood Draws to Measure Blood Protein Levels — 7.23; 6.86; 7.43; 7.21 grams per deciliter
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Genepro Gen2 Absorption and Protein Value Clinical Trial.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Weekly Blood Draws to Measure Blood Protein Levels |
7.23; 6.86; 7.43; 7.21; 7.1; 7.28 | — |
Eligibility Criteria
- 20 Post Op Gastric Bypass patients.
- 10 men,
- 10 women.
- Minimum age 30
- Maximum age 46
- All participants have been post operation from their weight loss surgery for a minimum of 3 months prior to the start of the study and no longer than 12 months at the start of the study.
Exclusion Criteria
- Any digestive distress disorder (IBS, Crones, etc).
Data sourced from ClinicalTrials.gov (NCT02919657). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.